Literature DB >> 19327744

Vitreomacular adhesion in active and end-stage age-related macular degeneration.

Craig D Robison1, Ilse Krebs, Susanne Binder, Irene A Barbazetto, Athanasios I Kotsolis, Lawrence A Yannuzzi, Alfredo A Sadun, Jerry Sebag.   

Abstract

PURPOSE: To evaluate vitreomacular relations in different stages of age-related macular degeneration (AMD) without the influence of genetics and environmental factors.
DESIGN: Retrospective, observational case series.
METHODS: This was a multicenter study consisting of 29 previously untreated subjects with active exudative (wet) AMD in one eye and active nonexudative (dry) AMD in the fellow eye who were compared with 10 previously untreated subjects with end-stage geographic atrophy in one eye and an end-stage fibrotic (disciform) scar in the fellow eye. All subjects were studied with ultrasonography to identify the presence of posterior vitreous detachment (PVD) and by optical coherence tomography to detect vitreomacular adhesion (VMA).
RESULTS: The incidence of PVD in eyes with nonexudative AMD was 20 (69%) of 29, compared with 6 (21%) of 29 with active exudative AMD (P = .002). VMA was present in 11 (38%) of 29 of eyes with exudative AMD and in only 3 (10%) of 29 eyes with nonexudative AMD (P = .008). The incidence of PVD in geographic atrophy was 7 (70%) of 10, compared with 4 (40%) of 10 with disciform scar (P = .44). VMA was present in 2 (20%) of 10 eyes with disciform scars and in 0 (0%) of 10 eyes with geographic atrophy (P = .48).
CONCLUSIONS: PVD may protect against exudative AMD, whereas VMA may promote exudative AMD. This phenomenon is not evident in end-stage disease because of an increased incidence of PVD and a decreased incidence of VMA in eyes with disciform scars. Genetic and environmental factors do not seem to influence these observations.

Entities:  

Mesh:

Year:  2009        PMID: 19327744     DOI: 10.1016/j.ajo.2009.01.014

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  37 in total

1.  [The vitreoretinal interface and its role in the pathogenesis of vitreomaculopathies].

Authors:  J Sebag
Journal:  Ophthalmologe       Date:  2015-01       Impact factor: 1.059

2.  Intracameral concentrations of the fibrinolytic system components in patients with age-related macular degeneration.

Authors:  Thomas Bertelmann; Marta Spychalska; Laura Kohlberger; Stefan Strodthoff; Michael Witteborn; Nadia Kicova; Ulrich Sachs; Sebastian Irle; Stefan Mennel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-12       Impact factor: 3.117

3.  Branch retinal vein occlusion and vitreovascular traction: a preliminary spectral domain OCT case-control study.

Authors:  Francisco J Ascaso; Esteban Padgett; Esther Núñez; Laura Villén; Andrzej Grzybowski; José A Cristóbal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-03       Impact factor: 3.117

4.  Effects of vitreomacular adhesion on ranibizumab treatment in Japanese patients with age-related macular degeneration.

Authors:  Yoko Nomura; Hidenori Takahashi; Xue Tan; Shigeto Fujimura; Ryo Obata; Yasuo Yanagi
Journal:  Jpn J Ophthalmol       Date:  2014-08-06       Impact factor: 2.447

5.  Effect of vitreomacular adhesion on antivascular endothelial growth factor therapy for macular edema secondary to branch retinal vein occlusion.

Authors:  Ryo Terao; Kentaro Yuda; Kayo Kure; Tatsuya Inoue; Hiroshi Ohtsu; Yasuo Yanagi
Journal:  Jpn J Ophthalmol       Date:  2014-01-10       Impact factor: 2.447

6.  Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials.

Authors:  Thomas A Ciulla; Thomas A Cuilla; Gui-Shuang Ying; Maureen G Maguire; Daniel F Martin; Glenn J Jaffe; Juan E Grunwald; Ebenezer Daniel; Cynthia A Toth
Journal:  Ophthalmology       Date:  2015-03-29       Impact factor: 12.079

7.  Effect of posterior vitreous detachment on aqueous humor level of vascular endothelial growth factor in exudative age-related macular degeneration patients.

Authors:  Yoko Nomura; Hidenori Takahashi; Xue Tan; Yujiro Fujino; Hidetoshi Kawashima; Yasuo Yanagi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-12       Impact factor: 3.117

8.  Gas-mediated vitreomacular adhesion release with intravitral ranibizumab injections for exudative age-related macular degeneration.

Authors:  Hae Min Kang; Sung Jun Lee; Chul Gu Kim; Eun Jee Chung; Hyoung Jun Koh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-08       Impact factor: 3.117

9.  Treatment of massive subretinal hematoma associated with age-related macular degeneration using vitrectomy with intentional giant tear.

Authors:  Eisuke Isizaki; Seita Morishita; Takaki Sato; Masanori Fukumoto; Hiroyuki Suzuki; Teruyo Kida; Mari Ueki; Tsunehiko Ikeda
Journal:  Int Ophthalmol       Date:  2015-07-28       Impact factor: 2.031

10.  Predicting visual outcomes for macular disease using optical coherence tomography.

Authors:  Pearse A Keane; Srinivas R Sadda
Journal:  Saudi J Ophthalmol       Date:  2011-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.